Avience Biomedicals IPO Subscription Status
Avience Biomedicals IPO was subscribed 385.4 times when bidding closed on 22 Jun 2026: QIB 196.77x, NII 597.63x, Retail 401.36x.
The Avience Biomedicals IPO has been subscribed 385.4x times overall. Retail investors have shown interest with bids for 401.36x the shares available. The Non-Institutional Investor (NII) category has been subscribed 597.63x. Qualified Institutional Buyers (QIBs) have subscribed 196.77x. Data last updated on 25 Aug, 12:54 PM.
The IPO subscription period has ended. Given the strong demand, the allotment process is expected to be highly competitive. The issue opened on 18 Jun, 2026 and closes on 22 Jun, 2026. The shares are expected to list on stock exchanges on 25 Jun, 2026.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Live bidding
Shares bid against shares offered, category by category, as published by the exchanges. Summary splits NII into bHNI (above ₹10 lakh) and sHNI (₹2–10 lakh); switch to Detailed for the exchange's own sub-category rows.
| Category | Bid details | Times |
|---|---|---|
| Anchor Investors | - of 4,09,800 | 1.00x |
| QIB | 5,38,37,400 of 2,73,600 | 196.77x |
| NII | 12,37,09,800 of 2,07,000 | 597.63x |
| Retail | 19,31,32,800 of 4,81,200 | 401.36x |
| TOTAL | 37,06,80,000 | 385.40x |
Application-wise breakup (estimated)
Approximate application counts — the exchanges don't publish these during bidding. Estimated from shares bid using the typical application size seen in recent IPOs' Basis of Allotment data. Max Applications is the number of allotment slots: one lot per retail winner, and the minimum NII application (the smallest lot count above ₹2 lakh) per sHNI and bHNI winner. Final counts appear here once the Basis of Allotment is out.
| Category | Est. Applied | Times | |
|---|---|---|---|
| Retail max 802 | 1,60,512 | 200.14x | |
| TOTAL (EST.) | 1,60,512 |
Avience Biomedicals IPO allotment probability
Your odds of an allotment in each category at the current subscription.
Odds = allotment slots ÷ applications, or the subscription multiple where counts aren't available. Retail and HNI allotment is by lottery; QIB is proportionate. Not investment advice.
Subscription insights
What the current book is saying, read off the category numbers above.
Retail Allotment
High demand detected. The retail category is heavily oversubscribed, making the allotment a lottery where only 1 out of every 402 applicants will be successful.
Market Sentiment
Strong grey market premium of 69.7% suggests exceptional listing gains and high bullish sentiment among traders.
Institutional Backing
Massive institutional interest with QIBs subscribing 196.77x. This often signals long-term confidence from professional funds.
Day-wise subscription history
End-of-day subscription across the 3-day bidding window. On phones, tap a day for the category split.
| Date | Total | ||
|---|---|---|---|
|
22 Jun 2026
Day 3 |
385.32x | ▼ | |
|
QIB196.77x
NII597.23x
Retail401.36x
|
|||
|
19 Jun 2026
Day 2 |
43.79x | ▼ | |
|
QIB-
NII66.36x
Retail58.97x
|
|||
|
18 Jun 2026
Day 1 |
10.75x | ▼ | |
|
QIB-
NII13.49x
Retail15.69x
|
|||
Avience Biomedicals SME IPO dates
From the bidding window to listing. Today is 1 November.
- Open 18 Jun 2026
- Close 22 Jun 2026
- Allotment 23 Jun 2026
- Refund/credit 24 Jun 2026
- Listing 25 Jun 2026
What does this subscription data mean?
IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:
- 01 QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
- 02 NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
- 03 Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
- 04 Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.
Data sourced from BSE/NSE. Subscription numbers are updated during bidding hours (10 AM – 5 PM IST) on active subscription days.
Frequently asked
What is the current subscription status of Avience Biomedicals IPO?
As of IPO close date (22 Jun, 2026), the Avience Biomedicals IPO is subscribed 385.40x times. Retail category is 401.36x, and NII is 597.63x subscribed.
When is the allotment date for Avience Biomedicals IPO?
The allotment for Avience Biomedicals IPO is expected to be finalized on 23 June, 2026.
What is the GMP of Avience Biomedicals?
The Grey Market Premium (GMP) for Avience Biomedicals is currently ₹145, indicating a potential listing gain of 69.7%.
When will Avience Biomedicals IPO list on the stock market?
Avience Biomedicals is scheduled to list on BSE and NSE on 25 June, 2026.
What are the chances of getting allotment in Avience Biomedicals IPO?
The retail category is oversubscribed at 401.36x, meaning allotment is by lottery. Statistically, approximately 1 in 402 applicants will receive allotment. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.
What does QIB subscription of 196.77x mean for Avience Biomedicals IPO?
Strong — QIBs (mutual funds, FIIs, insurance companies) have subscribed 196.77x, indicating high institutional conviction. Heavy QIB demand is historically one of the strongest predictors of a positive listing.
How to check Avience Biomedicals IPO allotment status?
After the allotment date (23 Jun, 2026), you can check your Avience Biomedicals IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.
Explore Avience Biomedicals SME IPO further
Track every stage of this IPO, from subscription to listing.
It has listed — go back to the fundamentals.
Live grey market premium, Kostak and Subject to Sauda, with the day-wise trend.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
Subscription moves by the hour. Get it on your phone.
Live GMP alerts, subscription updates and allotment status for every Mainboard and SME issue — fast, free and secure.
Not investment advice. Subscription figures are as published by BSE/NSE and change until bidding closes.
